These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1009761

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN, Aleksandrova LM, Kliachko VR, Mazovetskiĭ AG.
    Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract] [Full Text] [Related]

  • 6. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
    Fisanovich TI, Tolstova LG.
    Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
    [No Abstract] [Full Text] [Related]

  • 9. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
    Makinskiĭ AI, Safarov RN, Fondaminskaia LD, Semenova AS, Fedotova NN.
    Probl Tuberk; 1979 Jan; (1):26-30. PubMed ID: 368764
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate].
    Guerrera G, Melina D.
    Clin Ter; 1980 Mar 15; 92(5):533-47. PubMed ID: 7449327
    [No Abstract] [Full Text] [Related]

  • 13. Pyridinolcarbamate in the long-term treatment of ischaemic heart disease.
    Gulyás A, Szám I.
    Ther Hung; 1976 Mar 15; 24(2):63-6. PubMed ID: 982341
    [No Abstract] [Full Text] [Related]

  • 14. [Pyridinolcarbamate in the treatment of peripheral vascular diseases in diabetics. Observations after 3 years of clinical use].
    Parodi FA.
    Minerva Med; 1974 May 26; 65(40):2316-20. PubMed ID: 4421119
    [No Abstract] [Full Text] [Related]

  • 15. [Contribution of angioxine to the vascular protection of the diabetic].
    Journ Annu Diabetol Hotel Dieu; 1976 May 26; ():319-27. PubMed ID: 796526
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K, Oliva I, Linhart J, Prerovský I, Modr Z.
    Cas Lek Cesk; 1976 Aug 27; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of angioprotectors on the glomerular filtration rate and vascular permeability in diabetic angiopathies].
    Tirkina TN, Mirkhodzhaev AKh, Alekseev IuP, Ionushas BS, Kasymova SD.
    Probl Endokrinol (Mosk); 1979 Aug 27; 25(4):11-6. PubMed ID: 471968
    [Abstract] [Full Text] [Related]

  • 20. [Preliminary study of a work concerning the activity of pyridinol carbamate on diabetic angiopathy (study of the microcirculation)].
    Le Devehat C, Lemoine A.
    Journ Annu Diabetol Hotel Dieu; 1977 Aug 27; ():389-93. PubMed ID: 894879
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.